Login / Signup

Ataxin-7 and Non-stop coordinate SCAR protein levels, subcellular localization, and actin cytoskeleton organization.

Veronica CloudAda ThapaPedro Morales-SosaTayla M MillerSara A MillerDaniel HolsapplePaige M GerhartElaheh MomtahanJarrid L JackEdgardo LeivaSarah R RappLauren G SheltonRichard A PierceSkylar Martin-BrownLaurence FlorensMichael P WashburnRyan D Mohan
Published in: eLife (2019)
Atxn7, a subunit of SAGA chromatin remodeling complex, is subject to polyglutamine expansion at the amino terminus, causing spinocerebellar ataxia type 7 (SCA7), a progressive retinal and neurodegenerative disease. Within SAGA, the Atxn7 amino terminus anchors Non-stop, a deubiquitinase, to the complex. To understand the scope of Atxn7-dependent regulation of Non-stop, substrates of the deubiquitinase were sought. This revealed Non-stop, dissociated from Atxn7, interacts with Arp2/3 and WAVE regulatory complexes (WRC), which control actin cytoskeleton assembly. There, Non-stop countered polyubiquitination and proteasomal degradation of WRC subunit SCAR. Dependent on conserved WRC interacting receptor sequences (WIRS), Non-stop augmentation increased protein levels, and directed subcellular localization, of SCAR, decreasing cell area and number of protrusions. In vivo, heterozygous mutation of SCAR did not significantly rescue knockdown of Atxn7, but heterozygous mutation of Atxn7 rescued haploinsufficiency of SCAR.
Keyphrases
  • wound healing
  • transcription factor
  • early onset
  • single cell
  • binding protein
  • multiple sclerosis
  • gene expression
  • protein kinase
  • stem cells
  • cell therapy
  • oxidative stress
  • amino acid
  • small molecule
  • genome wide